ICDcodes.org
FY2027

E09.3523Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, bilateral

Billable

Is E09.3523 billable?

Yes — E09.3523 is billable for FY2027. E09.3523 is a valid, billable ICD-10-CM code at the highest level of specificity in its branch. E09.3523 may be submitted for encounters from October 1, 2026 through September 30, 2027.

E09.3523 at a glance

CodeE09.3523
DescriptionDrug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, bilateral
BillableYes
Code setICD-10-CM FY2027
Valid for encountersOctober 1, 2026 – September 30, 2027
7th character "3"bilateral

What does the 7th character "3" mean in E09.3523?

In E09.3523, the 7th character 3 means bilateral. The 7th character is required for E09.3523 to be a valid, complete code.

Same condition, different episode of care — switch the 7th character:

Which MS-DRGs does E09.3523 group to?

E09.3523 sits in MDC Pre and helps define the logic of 1 MS-DRG (version 44, FY2027). Which one a stay actually groups to also depends on procedures and secondary diagnoses.

  • 008Simultaneous Pancreas, Islet Cell and Kidney Transplantsurgical

How is E09.3523 listed in the Alphabetic Index?

The Alphabetic Index lists these routes under E09.352, the nearest indexed parent of E09.3523. Use them to find the family, then select the specific code.

  • Diabetes, diabeticdue to drug or chemicalwithretinopathyproliferativewithtraction retinal detachment involving the macula (mellitus) (sugar)

Excludes1 — never code together — inherited from Chapter 4

The conditions below can never be reported together with E09.3523 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.

  • transitory endocrine and metabolic disorders specific to newborn (P70-P74)

Excludes1 — never code together — inherited from E09

The conditions below can never be reported together with E09.3523 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.

  • diabetes mellitus due to underlying condition (E08.-)
  • gestational diabetes (O24.4-)
  • neonatal diabetes mellitus (P70.2)
  • postpancreatectomy diabetes mellitus (E13.-)
  • postprocedural diabetes mellitus (E13.-)
  • secondary diabetes mellitus NEC (E13.-)
  • type 1 diabetes mellitus (E10.-)
  • type 2 diabetes mellitus (E11.-)

Code first — inherited from E09

The underlying condition below must be sequenced before E09.3523. E09.3523 describes a manifestation and cannot be the principal or first-listed diagnosis.

  • poisoning due to drug or toxin, if applicable (T36-T65 with fifth or sixth character 1-4)

Use additional code — inherited from E09

Report an additional code alongside E09.3523 to fully describe the condition. E09.3523 is sequenced first.

  • code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
  • code to identify control using:
  • injectable non-insulin antidiabetic drugs (Z79.85)
  • insulin (Z79.4)
  • oral antidiabetic drugs (Z79.84)
  • oral hypoglycemic drugs (Z79.84)

How long has E09.3523 existed?

E09.3523 first appears in FY2018 (FY2017 is not available, so it may have appeared then).

Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.